1[1]Moore BW. A soluble protein characteristic of the nervous system[J]. Biochem Biophys Res Commun, 1965,19(6):739-744.
2[2]Michetti F, Gazzolo D. S100B protein in biological fluids:a tool for perinatal medicine[J]. Clin Chem, 2002,48(12):2097-2104.
3[4]Donato R. Intracellular and extracellular roles of S100proteins[J]. Microsc Res Tech, 2003,60(6):540-551.
4[5]Wainwright MS, Craft JM, Griffin WS, et al. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia[J]. Ann Neurol, 2004,56(1):61-67.
5[6]Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology,outcome prediction and neuroprotective drug monitoring[J]. Restor Neurol Neurosci, 2003,21(3-4): 177-190.
6[7]Ingebrigtsen T, Romner B. Serial S100 protein serum measurements related to early magnetic resonance imaging after minor head injury[J]. J Neurosurg, 1996, 85(5):945-948.
7[8]Arolt V, Peters M, Erfurth A, et al. S100B and response to treatment in major depression: a pilot study [J]. Eur Neuropsychopharmacol, 2003,13(4): 235-239.
8[9]Schroeter ML, Abdul-Khaliq H, Fruhauf S, et al. Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia [J]. Schizophr Res,2003,62(3):231-236.
9[11]Lardner D, Davidson A, McKenzie I, et al. Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass[J]. Paediatr Anaesth, 2004,14(6):495-500.
10[12]Snyder-Ramos SA, Gruhlke T, Bauer H, et al. Cerebral and extracerebral release of protein S100B in cardiac surgical patients[J]. Anaesthesia, 2004,59(4):344-349.
